We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$1.29B
AUM Growth
+$364M
Cap. Flow
+$345M
Cap. Flow %
26.79%
Top 10 Hldgs %
100%
Holding
16
New
2
Increased
5
Reduced
1
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 16.02%
2 Healthcare 13.95%
3 Communication Services 13.61%
4 Consumer Discretionary 8.13%
5 Energy 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$329M 25.53%
+1,600,000
New +$312M
GDX icon
2
VanEck Gold Miners ETF
GDX
$22.5B
$207M 16.11%
10,390,000
+4,150,000
+67% +$71.4M
PYPL icon
3
PayPal
PYPL
$50.3B
$206M 16.02%
5,345,000
+620,000
+13% +$22.4M
CHTR icon
4
Charter Communications
CHTR
$17.3B
$153M 11.87%
755,000
+65,000
+9% +$11.7M
TRIP icon
5
TripAdvisor
TRIP
$1.7B
$105M 8.13%
1,575,000
+572,727
+57% +$37.9M
PODD icon
6
Insulet
PODD
$11.8B
$90.2M 7%
2,720,000
ANDV
7
DELISTED
Andeavor
ANDV
$85.6M 6.64%
995,000
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$38.3B
$71.2M 5.53%
1,135,000
+410,000
+57% +$27.3M
TWC
9
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$22.5M 1.75%
110,000
-75,000
-41% -$14.2M
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$18.2M 1.41%
+430,000
New +$21.9M
KMI icon
11
Kinder Morgan
KMI
$70.9B
-1,030,000
Closed -$15.4M
OKE icon
12
Oneok
OKE
$56.7B
-805,000
Closed -$19.9M
WMB icon
13
Williams Companies
WMB
$85.8B
-660,000
Closed -$17M
Z icon
14
Zillow
Z
$7.78B
-2,385,000
Closed -$56M
MDCO
15
DELISTED
Medicines Co
MDCO
-570,000
Closed -$21.3M
CPGX
16
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
-805,000
Closed -$16.1M

Similar funds

Slate Path Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Slate Path Capital held 16 positions worth $1.29B, up 39% from $924M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Slate Path Capital deployed $345M of net new capital in Q1 2016, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 430,000 shares worth $18.2M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was TIME WARNER CABLE INC NEW COM STK, an estimated $14.2M trimmed.

  • Slate Path Capital's largest Q1 2016 buy was IVERIC bio, Inc. Common Stock: 430,000 shares worth $18.2M.
  • Slate Path Capital added most to VanEck Gold Miners ETF in Q1 2016, an estimated $71.4M increase.
  • Slate Path Capital's biggest Q1 2016 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $14.2M.
  • Slate Path Capital fully exited Zillow in Q1 2016, selling an estimated $56M.
  • Slate Path Capital's ten largest holdings make up 100% of its $1.29B portfolio in Q1 2016.
  • Slate Path Capital opened 2 new positions and closed 6 in Q1 2016.
  • Slate Path Capital's portfolio value rose 39% quarter-over-quarter to $1.29B.

Based on Slate Path Capital's 13F filing for Q1 2016, filed 16 May 2016.